{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T11:32:59Z","timestamp":1744716779257},"reference-count":43,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Virus Research"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.virusres.2010.09.014","type":"journal-article","created":{"date-parts":[[2010,9,30]],"date-time":"2010-09-30T09:01:38Z","timestamp":1285837298000},"page":"156-162","source":"Crossref","is-referenced-by-count":4,"title":["Comparative immunogenicity of recombinant adenovirus-vectored vaccines expressing different forms of hemagglutinin (HA) proteins from the H5 serotype of influenza A viruses in mice"],"prefix":"10.1016","volume":"155","author":[{"given":"Xiangjing","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weixu","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenyuan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiqi","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caijun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9523","key":"10.1016\/j.virusres.2010.09.014_bib0005","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/S0140-6736(06)68656-X","article-title":"Safety and immunogenicity of an inactivated split-virion influenza A\/Vietnam\/1194\/2004 (H5N1) vaccine: phase I randomised trial","volume":"367","author":"Bresson","year":"2006","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.virusres.2010.09.014_bib0010","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1128\/JVI.01443-08","article-title":"Optimization of human immunodeficiency virus gag expression by newcastle disease virus vectors for the induction of potent immune responses","volume":"83","author":"Carnero","year":"2009","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.virusres.2010.09.014_bib0015","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00430-007-0052-3","article-title":"The threat of avian influenza A (H5N1). Part IV: development of vaccines","volume":"196","author":"Cinatl","year":"2007","journal-title":"Med. Microbiol. Immunol."},{"issue":"6651","key":"10.1016\/j.virusres.2010.09.014_bib0020","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/39218","article-title":"A pandemic warning?","volume":"389","author":"de Jong","year":"1997","journal-title":"Nature"},{"issue":"9622","key":"10.1016\/j.virusres.2010.09.014_bib0025","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/S0140-6736(08)60627-3","article-title":"Human infection with highly pathogenic H5N1 influenza virus","volume":"371","author":"Gambotto","year":"2008","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.virusres.2010.09.014_bib0030","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1128\/JVI.80.4.1959-1964.2006","article-title":"Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization","volume":"80","author":"Gao","year":"2006","journal-title":"J. Virol."},{"issue":"9509","key":"10.1016\/j.virusres.2010.09.014_bib0035","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0140-6736(06)68076-8","article-title":"Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in mice","volume":"367","author":"Hoelscher","year":"2006","journal-title":"Lancet"},{"issue":"25\u201326","key":"10.1016\/j.virusres.2010.09.014_bib0040","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1016\/S0264-410X(02)00268-2","article-title":"Eight-plasmid system for rapid generation of influenza virus vaccines","volume":"20","author":"Hoffmann","year":"2002","journal-title":"Vaccine"},{"issue":"36","key":"10.1016\/j.virusres.2010.09.014_bib0045","doi-asserted-by":"crossref","first-page":"12915","DOI":"10.1073\/pnas.0506416102","article-title":"Role of specific hemagglutinin amino acids in the immunogenicity and protection of H5N1 influenza virus vaccines","volume":"102","author":"Hoffmann","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"11","key":"10.1016\/j.virusres.2010.09.014_bib0050","doi-asserted-by":"crossref","first-page":"6108","DOI":"10.1073\/pnas.100133697","article-title":"A DNA transfection system for generation of influenza A virus from eight plasmids","volume":"97","author":"Hoffmann","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"17","key":"10.1016\/j.virusres.2010.09.014_bib0055","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.1016\/j.vaccine.2005.07.005","article-title":"The development and characterization of H5 influenza virus vaccines derived from a 2003 human isolate","volume":"24","author":"Horimoto","year":"2006","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.virusres.2010.09.014_bib0060","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1086\/517614","article-title":"Recombinant modified vaccinia virus Ankara-based vaccine induces protective immunity in mice against infection with influenza virus H5N1","volume":"195","author":"Kreijtz","year":"2007","journal-title":"J. Infect. Dis."},{"issue":"6996","key":"10.1016\/j.virusres.2010.09.014_bib0065","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nature02746","article-title":"Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia","volume":"430","author":"Li","year":"2004","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.virusres.2010.09.014_bib0070","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1086\/314713","article-title":"Recombinant influenza A virus vaccines for the pathogenic human A\/Hong Kong\/97 (H5N1) viruses","volume":"179","author":"Li","year":"1999","journal-title":"J. Infect. Dis."},{"issue":"9540","key":"10.1016\/j.virusres.2010.09.014_bib0075","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0140-6736(06)69294-5","article-title":"Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial","volume":"368","author":"Lin","year":"2006","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.virusres.2010.09.014_bib0080","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1086\/428951","article-title":"Efficacy of H5 influenza vaccines produced by reverse genetics in a lethal mouse model","volume":"191","author":"Lipatov","year":"2005","journal-title":"J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.virusres.2010.09.014_bib0085","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S0042-6822(03)00458-6","article-title":"Preparation of a standardized, efficacious agricultural H5N3 vaccine by reverse genetics","volume":"314","author":"Liu","year":"2003","journal-title":"Virology"},{"issue":"46","key":"10.1016\/j.virusres.2010.09.014_bib0090","doi-asserted-by":"crossref","first-page":"16825","DOI":"10.1073\/pnas.0505587102","article-title":"An improved reverse genetics system for influenza A virus generation and its implications for vaccine production","volume":"102","author":"Neumann","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"16","key":"10.1016\/j.virusres.2010.09.014_bib0095","doi-asserted-by":"crossref","first-page":"9345","DOI":"10.1073\/pnas.96.16.9345","article-title":"Generation of influenza A viruses entirely from cloned cDNAs","volume":"96","author":"Neumann","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"9272","key":"10.1016\/j.virusres.2010.09.014_bib0100","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1016\/S0140-6736(00)05066-2","article-title":"Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A\/Duck\/Singapore\/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza","volume":"357","author":"Nicholson","year":"2001","journal-title":"Lancet"},{"issue":"22","key":"10.1016\/j.virusres.2010.09.014_bib0105","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1016\/j.vaccine.2004.08.054","article-title":"Generation of influenza vaccine viruses on Vero cells by reverse genetics: an H5N1 candidate vaccine strain produced under a quality system","volume":"23","author":"Nicolson","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2010.09.014_bib0110","series-title":"Advanced Laboratory Techniques for Influenza Diagnosis: Procedural Guide","author":"Palmer","year":"1975"},{"issue":"9409","key":"10.1016\/j.virusres.2010.09.014_bib0115","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0140-6736(04)15595-5","article-title":"Re-emergence of fatal human influenza A subtype H5N1 disease","volume":"363","author":"Peiris","year":"2004","journal-title":"Lancet"},{"issue":"13","key":"10.1016\/j.virusres.2010.09.014_bib0120","doi-asserted-by":"crossref","first-page":"5997","DOI":"10.1128\/JVI.74.13.5997-6005.2000","article-title":"Enhancement of primary and secondary cellular immune responses against human immunodeficiency virus type 1 Gag by using DNA expression vectors that target Gag antigen to the secretory pathway","volume":"74","author":"Qiu","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2010.09.014_bib0125","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1086\/514176","article-title":"DNA immunization for influenza virus: studies using hemagglutinin- and nucleoprotein-expressing DNAs","volume":"176 (Suppl.)","author":"Robinson","year":"1997","journal-title":"J. Infect. Dis."},{"issue":"17\u201319","key":"10.1016\/j.virusres.2010.09.014_bib0130","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1016\/S0264-410X(00)00495-3","article-title":"Genetic adjuvants for DNA vaccines","volume":"19","author":"Scheerlinck","year":"2001","journal-title":"Vaccine"},{"issue":"6869","key":"10.1016\/j.virusres.2010.09.014_bib0215","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/415331a","article-title":"Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity","volume":"415","author":"Shiver","year":"2002","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.virusres.2010.09.014_bib0135","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/j.1460-2075.1990.tb08155.x","article-title":"Intracellular transport of soluble and membrane-bound glycoproteins: folding, assembly and secretion of anchor-free influenza hemagglutinin","volume":"9","author":"Singh","year":"1990","journal-title":"EMBO J."},{"issue":"5772","key":"10.1016\/j.virusres.2010.09.014_bib0140","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1126\/science.1124513","article-title":"Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus","volume":"312","author":"Stevens","year":"2006","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.virusres.2010.09.014_bib0145","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1006\/viro.2002.1742","article-title":"Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse genetics","volume":"305","author":"Subbarao","year":"2003","journal-title":"Virology"},{"issue":"4","key":"10.1016\/j.virusres.2010.09.014_bib0150","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nri2054","article-title":"Scientific barriers to developing vaccines against avian influenza viruses","volume":"7","author":"Subbarao","year":"2007","journal-title":"Nat. Rev. Immunol."},{"issue":"5349","key":"10.1016\/j.virusres.2010.09.014_bib0155","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1126\/science.279.5349.393","article-title":"Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness","volume":"279","author":"Subbarao","year":"1998","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.virusres.2010.09.014_bib0160","doi-asserted-by":"crossref","first-page":"8303","DOI":"10.1128\/JVI.73.10.8303-8307.1999","article-title":"Avirulent avian influenza virus as a vaccine strain against a potential human pandemic","volume":"73","author":"Takada","year":"1999","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virusres.2010.09.014_bib0165","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.virol.2005.07.011","article-title":"Protective efficacy in chickens, geese and ducks of an H5N1-inactivated vaccine developed by reverse genetics","volume":"341","author":"Tian","year":"2005","journal-title":"Virology"},{"issue":"13\u201314","key":"10.1016\/j.virusres.2010.09.014_bib0170","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/S0264-410X(00)00395-9","article-title":"Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans","volume":"19","author":"Treanor","year":"2001","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.virusres.2010.09.014_bib0175","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1056\/NEJMoa044021","article-title":"Probable person-to-person transmission of avian influenza A (H5N1)","volume":"352","author":"Ungchusak","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.virusres.2010.09.014_bib0180","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.vaccine.2004.07.043","article-title":"Safety and immunogenicity of adenovirus-vectored nasal and epicutaneous influenza vaccines in humans","volume":"23","author":"Van Kampen","year":"2005","journal-title":"Vaccine"},{"issue":"21","key":"10.1016\/j.virusres.2010.09.014_bib0185","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1016\/j.vaccine.2005.08.023","article-title":"Relative contributions of codon usage, promoter efficiency and leader sequence to the antigen expression and immunogenicity of HIV-1 Env DNA vaccine","volume":"24","author":"Wang","year":"2006","journal-title":"Vaccine"},{"issue":"25\u201326","key":"10.1016\/j.virusres.2010.09.014_bib0190","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.1016\/j.vaccine.2004.02.036","article-title":"A DNA vaccine producing LcrV antigen in oligomers is effective in protecting mice from lethal mucosal challenge of plague","volume":"22","author":"Wang","year":"2004","journal-title":"Vaccine"},{"issue":"23","key":"10.1016\/j.virusres.2010.09.014_bib0195","doi-asserted-by":"crossref","first-page":"11628","DOI":"10.1128\/JVI.01065-06","article-title":"Hemagglutinin (HA) proteins from H1 and H3 serotypes of influenza A viruses require different antigen designs for the induction of optimal protective antibody responses as studied by codon-optimized HA DNA vaccines","volume":"80","author":"Wang","year":"2006","journal-title":"J. Virol."},{"issue":"9415","key":"10.1016\/j.virusres.2010.09.014_bib0200","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0140-6736(04)15892-3","article-title":"Responsiveness to a pandemic alert: use of reverse genetics for rapid development of influenza vaccines","volume":"363","author":"Webby","year":"2004","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.virusres.2010.09.014_bib0205","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/nrmicro979","article-title":"From lethal virus to life-saving vaccine: the development of inactivated influenza vaccines for pandemic influenza","volume":"2","author":"Wood","year":"2004","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.virusres.2010.09.014_bib0210","series-title":"Cumulative Number of Confirmed Human Cases of Avian Influenza A\/(H5N1) Reported to WHO","author":"World Health Organization","year":"2010"}],"container-title":["Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170210003503?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170210003503?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T07:52:26Z","timestamp":1591948346000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168170210003503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S0168170210003503"],"URL":"https:\/\/doi.org\/10.1016\/j.virusres.2010.09.014","relation":{},"ISSN":["0168-1702"],"issn-type":[{"value":"0168-1702","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}